Center-Authored Papers

Filters: Author is Jagasia, Madan  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
*Whole-Body Irradiation
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
2008
Lee SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, Jagasia M, Kernan NA, Loberiza FR, Bevans M et al..  2008.  Variation in supportive care practices in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(11):1231-8. Abstract
Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M.  2008.  Individual physician practice variation in hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(13):2162-70. Abstract
2009
Ringdén O, Pavletic SZ, Anasetti C, Barrett JA, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C et al..  2009.  The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.. Blood. 113(13):3110-8. Abstract
O'Brien S, Berman E, Borghaei H, DeAngelo DJ, DeVetten MP, Devine S, Erba HP, Gotlib J, Jagasia M, Moore JO et al..  2009.  NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):984-1023.
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Gasparetto C, Huff CA et al..  2009.  NCCN clinical practice guidelines in oncology: multiple myeloma.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):908-42.
2011
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers MED, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT et al..  2011.  Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1):124-32. Abstract
Pidala J, Kurland BF, Chai X, Majhail N, Weisdorf DJ, Pavletic S, Cutler C, Jacobsohn D, Palmer J, Arai S et al..  2011.  Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.. Blood. 117(17):4651-7. Abstract
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
Arai S, Jagasia M, Storer BE, Chai X, Pidala J, Cutler C, Arora M, Weisdorf DJ, Flowers MED, Martin PJ et al..  2011.  Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.. Blood. 118(15):4242-4249. Abstract
Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers MED, Cutler CS, Urbano-Ispizua A, Antin JH, Bolwell BJ, Boyiadzis M et al..  2011.  Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.. Blood. 117(24):6714-20. Abstract
2012
Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang M-J et al..  2012.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.. Blood. 119(1):296-307. Abstract
Jacobsohn DA, Kurland BF, Pidala J, Inamoto Y, Chai X, Palmer JM, Arai S, Arora M, Jagasia M, Cutler C et al..  2012.  Correlation between NIH composite skin score, patient reported skin score and outcome: results from the Chronic GVHD Consortium.. Blood. 120(13):2545-52. Abstract
Inamoto Y, Martin PJ, Chai X, Jagasia M, Palmer J, Pidala J, Cutler C, Pavletic SZ, Arora M, Jacobsohn D et al..  2012.  Clinical Benefit of Response in Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(10):1517-24. Abstract
Pidala J, Vogelsang G, Martin P, Chai X, Storer B, Pavletic S, Weisdorf DJ, Jagasia M, Cutler C, Palmer J et al..  2012.  Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study.. Haematologica. 97(3):451-8. Abstract
2013
Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS, Cutler C, Weisdorf D, Kurland BF, Carpenter PA et al..  2013.  Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Pidala J, Chai X, Kurland BF, Inamoto Y, Flowers MED, Palmer J, Khera N, Jagasia M, Cutler C, Arora M et al..  2013.  Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(5):784-91. Abstract
Inamoto Y, Pidala J, Chai X, Kurland BF, Weisdorf D, Flowers MED, Palmer J, Arai S, Jacobsohn D, Cutler C et al..  2014.  Joint and fascia manifestations in chronic graft-versus-host disease and their assessment.. Arthritis and rheumatism. 66(4):1044-52. Abstract
Pidala J, Chai X, Martin P, Inamoto Y, Cutler C, Palmer J, Weisdorf D, Pavletic S, Arora M, Jagasia M et al..  2013.  Hand Grip Strength and 2-Minute Walk Test in Chronic Graft-versus-Host Disease Assessment: Analysis from the Chronic GVHD Consortium.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(6):967-972. Abstract
O'Brien S, Radich JP, Abboud CN, Akhtari M, Altman JK, Berman E, DeAngelo DJ, Deininger M, Devine S, Fathi AT et al..  2013.  Chronic Myelogenous Leukemia, Version 1.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(11):1327-40. Abstract
2014
Inamoto Y, Pidala J, Chai X, Kurland BF, Weisdorf D, Flowers MED, Palmer J, Arai S, Jacobsohn D, Cutler C et al..  2014.  Joint and fascia manifestations in chronic graft-versus-host disease and their assessment.. Arthritis and rheumatism. 66(4):1044-52. Abstract
Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Muller CR, Verneris MR, Savani BN, Jagasia M.  2014.  Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Single Nucleotide Polymorphisms Are Not Associated with Outcomes after Unrelated Donor Transplant: A Center for International Blood and Marrow Transplant Research Analysis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
El-Jawahri A, Pidala J, Inamoto Y, Chai X, Khera N, Wood WA, Cutler C, Arora M, Carpenter PA, Palmer J et al..  2014.  Impact of Age on Quality of Life, Functional Status and Survival in Patients with Chronic Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Inamoto Y, Martin PJ, Storer BE, Palmer J, Weisdorf D, Pidala J, Flowers MED, Arora M, Jagasia M, Arai S et al..  2014.  Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease.. Haematologica. 99(10):1618-23. Abstract